NCT07145307 Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial
| NCT ID | NCT07145307 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helse Stavanger HF |
| Condition | Anxiety Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2025-10-20 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2025-10-20 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility study is to test whether a new blended digital intervention for adolescents with anxiety disorders is feasible and acceptable for use, and to help plan future larger scale studies. The main questions it aims to answer are: * A: Can the investigators recruit appropriate participants? * B: How appropriate are the data collection procedures and outcome measures? * C: Are the study procedures and interventions suitable for and acceptable to the participants? * D: Does the research team have the resources and ability to manage the study and intervention? * E: Does the intervention show promise of being successful for adolescents with anxiety disorders? Participants will: * Receive outpatient anxiety treatment, typically every other week or weekly. * Use the Sidekick app as a homework supplement to plan, carry out, and evaluate exposure exercises between treatment sessions. * Complete questionnaires before, during, after, and three months after using the app. * Some participants and therapists will be invited to take part in qualitative interviews following the intervention.
Eligibility Criteria
Inclusion Criteria: * 13 to 18 years old * Adequate Norwegian reading, writing and speaking skills * Access to the internett and a smart-phone * Diagnosed anxiety disorder * Receiving outpatient treatment for their anxiety disorder * Exposure therapy included in therapy during the study period * Therapist agrees to incorporate the app as an ad-on to therapy * For patients receiving medication, inclusion requires a stable dose of medication for a psychiatric disorder for six weeks Exclusion Criteria: * Participants with serious mental illness, such as suicidality or poor general functioning may be excluded if participation is considered unfeasible or potentially harmful. Decision will be based on collaborative evaluation by the participants therapist and the research-team.
Contact & Investigator
Aleksander H Erga, PhD
STUDY DIRECTOR
KORFOR, Helse Stavanger
Frequently Asked Questions
Who can join the NCT07145307 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Anxiety Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07145307 currently recruiting?
Yes, NCT07145307 is actively recruiting participants. Contact the research team at pia.rygg.hauge@sus.no for enrollment information.
Where is the NCT07145307 trial being conducted?
This trial is being conducted at Stavanger, Norway, Stavanger, Norway.
Who is sponsoring the NCT07145307 clinical trial?
NCT07145307 is sponsored by Helse Stavanger HF. The principal investigator is Aleksander H Erga, PhD at KORFOR, Helse Stavanger. The trial plans to enroll 46 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.